![]() |
As the population ages, the number of people with Alzheimer’s disease in Europe will double by 2050. Image Credit: Gerd Altmann |
A task force led by UNIGE and HUG is laying the foundations for a preventive protocol.
Memory loss, behavioral changes, cognitive deficits: Alzheimer’s disease leads to a dramatic loss of autonomy for those affected and has a heavy impact on health costs. Its prevention has become a real social challenge. An international task force, led by the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG), is setting out guidelines for innovative services to prevent Alzheimer’s disease. These will soon be an integral part of second-generation memory clinics. These guidelines are detailed in an article published in the Lancet Regional Health - Europe.
With 10 million people affected in Europe, Alzheimer’s disease is the most common neurodegenerative disease. It is characterized by progressive disabling memory loss and cognitive deficits caused by an accumulation of toxic proteins in the brain. Its social and economic impact is considerable. On a global scale, it is estimated to be worth around USD 1,500 billion per year* and in Switzerland CHF 11.8 billion per year**.